Glycolysis-dependent histone deacetylase 4 degradation regulates inflammatory cytokine production

Molecular Biology of the Cell

Volumn 25, Issue 21, 2014, Pages 3300-3307

  Wang, Bin ^a,b   Liu, Ting Yu ^a   Lai, Chun Hsiang ^a   Rao, Yan Hua ^a   Choi, Moon Chang ^a   Chi, Jen Tsan ^a   Dai, Jian Wu ^b   Rathmell, Jeffrey C ^a   Yao, Tso Pang ^a  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INSTITUTE OF GENETICS AND DEVELOPMENTAL BIOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; GLYCOGEN SYNTHASE KINASE 3BETA; HISTONE DEACETYLASE 4; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; NITRIC OXIDE; PROTEIN P70; S6 KINASE; CYTOKINE; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA; HDAC5 PROTEIN, MOUSE; HISTONE DEACETYLASE; NOS2 PROTEIN, MOUSE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVATION; ENZYME DEGRADATION; ENZYME INHIBITION; GLYCOLYSIS; INFLAMMATION; MACROPHAGE; MUTANT; NEGATIVE FEEDBACK; NONHUMAN; SIGNAL TRANSDUCTION; ANIMAL; CELL LINE; CYTOLOGY; DRUG EFFECTS; GENETICS; METABOLISM; MICROGLIA; MOUSE; MUTATION; PHYSIOLOGY;

ANIMALS; CASPASE 3; CELL LINE; CYTOKINES; GLYCOGEN SYNTHASE KINASE 3; GLYCOLYSIS; HISTONE DEACETYLASES; INFLAMMATION; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; MICROGLIA; MUTATION; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; RIBOSOMAL PROTEIN S6 KINASES, 70-KDA;

EID: 84908657774     PISSN: 10591524     EISSN: 19394586     Source Type: Journal    
DOI: 10.1091/mbc.E13-12-0757     Document Type: Article

References (28)

1. Aka JA, Kim GW, Yang XJ (2011). K-acetylation and its enzymes: overview and new developments. Handb Exp Pharmacol 206, 1-12.
2. Almeida A, Moncada S, Bolanos JP (2004). Nitric oxide switches on glycolysis through the AMP protein kinase and 6-phosphofructo-2-kinase pathway. Nat Cell Biol 6, 45-51.
3. Carafa V, Miceli M, Altucci L, Nebbioso A (2013). Histone deacetylase inhibitors: a patent review (2009-2011). Expert Opin Ther Pat 23, 1-17.
4. Cernotta N, Clocchiatti A, Florean C, Brancolini C (2011). Ubiquitin-dependent degradation of HDAC4, a new regulator of random cell motility. Mol Biol Cell 22, 278-289.
5. Chin AI, Dempsey PW, Bruhn K, Miller JF, Xu Y, Cheng G (2002). Involvement of receptor-interacting protein 2 in innate and adaptive immune responses. Nature 416, 190-194.
6. Choi MC, Cohen TJ, Barrientos T, Wang B, Li M, Simmons BJ, Yang JS, Cox GA, Zhao Y, Yao TP (2012). A direct HDAC4-MAP kinase crosstalk activates muscle atrophy program. Mol Cell 47, 122-132.
7. Choudhary C, Kumar C, Gnad F, Nielsen ML, Rehman M, Walther TC, Olsen JV, Mann M (2009). Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science 325, 834-840.
8. Fan H, Cook JA (2004). Molecular mechanisms of endotoxin tolerance. J Endotoxin Res 10, 71-84.
9. Garbes L, Riessland M, Wirth B (2013). Histone acetylation as a potential therapeutic target in motor neuron degenerative diseases. Curr Pharm Des 19, 5093-50104.
10. Grabiec AM, Krausz S, de Jager W, Burakowski T, Groot D, Sanders ME, Prakken BJ, Maslinski W, Eldering E, Tak PP, et al. (2010). Histone deacetylase inhibitors suppress inflammatory activation of rheumatoid arthritis patient synovial macrophages and tissue. J Immunol 184, 2718-2728.
11. Kim SO, Ono K, Han J (2001). Apoptosis by pan-caspase inhibitors in lipopolysaccharide-activated macrophages. Am J Physiol Lung Cell Mol Physiol 281, L1095-L1105.
12. Krawczyk CM, Holowka T, Sun J, Blagih J, Amiel E, DeBerardinis RJ, Cross JR, Jung E, Thompson CB, Jones RG, et al. (2010). Toll-like receptor-induced changes in glycolytic metabolism regulate dendritic cell activation. Blood 115, 4742-4749.
13. Leoni F, Zaliani A, Bertolini G, Porro G, Pagani P, Pozzi P, Dona G, Fossati G, Sozzani S, Azam T, et al. (2002). The antitumor histone deacetylase inhibitor suberoylanilide hydroxamic acid exhibits antiinflammatory properties via suppression of cytokines. Proc Natl Acad Sci USA 99, 2995-3000.
14. Liu F, Dowling M, Yang XJ, Kao GD (2004). Caspase-mediated specific cleavage of human histone deacetylase 4. J Biol Chem 279, 34537-34546.
15. Lopez-Pelaez M, Fumagalli S, Sanz C, Herrero C, Guerra S, Fernandez M, Alemany S (2012). Cot/tpl2-MKK1/2-Erk1/2 controls mTORC1-mediated mRNA translation in Toll-like receptor-activated macrophages. Mol Biol Cell 23, 2982-2992.
16. Marrack P, Scott-Browne J, MacLeod MK (2010). Terminating the immune response. Immunol Rev 236, 5-10.
17. Martin S, Dicou E, Vincent JP, Mazella J (2005). Neurotensin and the neurotensin receptor-3 in microglial cells. J Neurosci Res 81, 322-326.
18. Moresi V, Williams AH, Meadows E, Flynn JM, Potthoff MJ, McAnally J, Shelton JM, Backs J, Klein WH, Richardson JA, et al. (2010). Myogenin and class II HDACs control neurogenic muscle atrophy by inducing E3 ubiquitin ligases. Cell 143, 35-45.
19. Norris KL, Lee JY, Yao TP (2009). Acetylation goes global: the emergence of acetylation biology. Sci Signal 2, pe76.
20. Palsson-McDermott EM, O'Neill LA (2004). Signal transduction by the lipopolysaccharide receptor, Toll-like receptor-4. Immunology 113, 153-162.
21. Paroni G, Mizzau M, Henderson C, Del Sal G, Schneider C, Brancolini C (2004). Caspase-dependent regulation of histone deacetylase 4 nuclear-cytoplasmic shuttling promotes apoptosis. Mol Biol Cell 15, 2804-2818.
22. Perry VH, Gordon S (1988). Macrophages and microglia in the nervous system. Trends Neurosci 11, 273-277.
23. Qiu T, Zhou L, Zhu W, Wang T, Wang J, Shu Y, Liu P (2013). Effects of treatment with histone deacetylase inhibitors in solid tumors: a review based on 30 clinical trials. Future Oncol 9, 255-269.
24. Rodriguez-Prados JC, Traves PG, Cuenca J, Rico D, Aragones J, Martin-Sanz P, Cascante M, Bosca L (2010). Substrate fate in activated macrophages: a comparison between innate, classic, and alternative activation. J Immunol 185, 605-614.
25. Vander Heiden MG, Plas DR, Rathmell JC, Fox CJ, Harris MH, Thompson CB (2001). Growth factors can influence cell growth and survival through effects on glucose metabolism. Mol Cell Biol 21, 5899-5912.
26. Vats D, Mukundan L, Odegaard JI, Zhang L, Smith KL, Morel CR, Wagner RA, Greaves DR, Murray PJ, Chawla A (2006). Oxidative metabolism and PGC-1beta attenuate macrophage-mediated inflammation. Cell Metab 4, 13-24.
27. Yuskaitis CJ, Jope RS (2009). Glycogen synthase kinase-3 regulates microglial migration, inflammation, and inflammation-induced neurotoxicity. Cell Signal 21, 264-273.
28. Zhao X, Ito A, Kane CD, Liao TS, Bolger TA, Lemrow SM, Means AR, Yao TP (2001). The modular nature of histone deacetylase HDAC4 confers phosphorylation-dependent intracellular trafficking. J Biol Chem 276, 35042-35048.